Livanova USA, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$114Mgeneral payments (2019-2025)
$169Kresearch payments (2019-2025)
12,240clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $15M
2020 $11M
2021 $14M
2022 $16M
2023 $18M
2024 $19M
2025 $20M

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Neurology (Psychiatry & Neurology) $104M
Neurology With Special Qualifications In Child Neurology $1.9M
Psychiatry $1.4M
Thoracic Surgery (Cardiothoracic Vascular Surgery) $1.2M
Epilepsy $647K
Internal Medicine $422K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Ivan Osorio Kansas City, KS Neurology (Psychiatry & Neurology) $101,682,624.81
Ahmed Abdelmoity Kansas City, MO Neurology With Special Qualifications In Child Neurology $775,921.27
Augustus Rush Dallas, TX Psychiatry $607,364.68
Kathryn Polovitz Parker, CO Internal Medicine $379,107.20
Danielle Becker Columbus, OH Epilepsy $370,972.24
Angus Wilfong Phoenix, AZ Neurology With Special Qualifications In Child Neurology $292,035.11
Alan Schwartz Baltimore, MD Pulmonary Disease $280,744.45
Scott Aaronson Baltimore, MD Psychiatry $245,266.57
Mark Cooper Hampton, VA Thoracic Surgery (Cardiothoracic Vascular Surgery) $213,906.48
Atul Malhotra San Diego, CA Sleep Medicine (Internal Medicine) $184,253.35

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.